Document ID: chunk:federal_register_of_legislation:F2024L01591:clause:1_3
Version: federal_register_of_legislation:F2024L01591
Segment Type: clause
Provision Reference: sch 1 cl 3
Character Range: 3341–3991

3  At the end of subsection 10(4)
Add:

           ; and (m) where the medicine is intended for electrolyte replacement and is manufactured or imported on or after 1 December 2026 – a statement, located immediately below the text mentioned in subsection 9(3), of:

              (i) for potassium chloride, and unless precluded by the container size—the equivalent quantity of potassium chloride in weight (in relation to the stated volume of fill of the injection); and

              (ii) for all other active ingredients—the equivalent quantity of each active ingredient in millimoles (in relation to the stated volume of fill of the injection).